Dr. Fadol was a Clinical Nurse Specialist of the Cardiovascular ICU at the Methodist Hospital and the Coordinator of the Heart Failure Program at Kelsey-Seybold at Houston, Texas.  She is now an Associate Professor and the coordinator of the “Heart Success Program”, at University of Texas, MD Anderson Cancer Center.  Dr. Fadol spearheaded a patient-centered, nurse-driven, interdisciplinary “Heart Success Program” at MD Anderson Cancer Center, resulting in a significant decrease (31/7% to 8.27%) in the 30-day hospital readmission rate for heart failure.  To advance cardio-oncology, she conducted yearly conferences on “Cardiac Complications of Cancer Therapy”.  Consequently, she has been invited with the consulting team to discuss the nurses’ role in a cardio-oncology program for Banner Health, a non-profit health system with 28 hospitals across the United States.  The nurses she mentored subsequently started cardio-oncology clinics in their institutions in Indiana and Korea.

Dr. Fadol has made significant research and practice contributions in the evolving cardio-oncology specialty for the management of cardiovascular issues in cancer patient and survivors.  She developed 7 educational materials for patients and nurses, presented at 47 national and 41 international conferences, conducted clinical research, published 23 manuscripts in peer-reviewed journals, 10 book chapters.  She is an associate editor of the Cardio-Oncology, the official journal of the International Cardio-Oncology Society.  She is the first nurse selected to serve in the leadership council of the cardio-oncology section, American College of Cardiology.  He developed and validated the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF) instrument for early identification of symptoms in cancer patients with heart failure.

She contributed to the development of cardiovascular nursing in Hong Kong since 1997 through education, lectureship, and research.  She was an invited speaker at the inaugural Asia Pacific Advanced Heart Failure Forum at The Chinese University of Hong Kong (2017).  She also conducted lectures virtually on “Cardiovascular Complications of Cancer Therapy” to nursing students at the Chinese University in Hong Kong, and in collaboration with the faculty, the MDASI-HF symptom assessment instrument was validated in Chinese.  Dr. Fadol had also presented at various national conferences including the Cardiovascular Nursing Conference (2012), American Association of Heart Failure Nurses Annual Conference (2015), and the National Comprehensive Cancer Network (2016, 2018).  In additional, she was invited to be moderator for the American College of Cardiology cardio-oncology conference (2012), and panelist (2017, 2019), attended by more than 300 cardiologists, advanced practice providers and nurses.

In recognition of her outstanding contributions and demonstrated commitment, she was granted 7 awards for excellence in patient education and clinical research, and inducted as a fellow of the American Academy of Nurse Practitioners (2010), and as a fellow of the American Academy of Nursing (2019).